
-
Antonio Banderas rules out retirement as he turns 65
-
Israel far right presses Netanyahu for decisive win against Hamas
-
Salah criticises UEFA for 'Palestinian Pele' tribute: 'Tell us how he died'
-
Italian Brainrot: the AI memes only kids know
-
Son Heung-min makes instant impact in LAFC debut
-
Armenians caught between hope and distrust after accord with Azerbaijan
-
Dropped Australian Test star Labuschagne plots Ashes return
-
European leaders urge more 'pressure' on Russia ahead of Trump-Putin summit
-
Defending champs Sinner, Sabalenka make winning starts in Cincinnati
-
Teen darts sensation Littler wins first World Series crown of year
-
TERRY COLE FIX IT! DEA Blocks FDA Cannabis Trials While Contaminated Marijuana Floods State Markets
-
Fleetwood clings to one-stroke PGA St. Jude lead over Rose
-
Messi to miss Miami's MLS Orlando clash
-
Nunez leaves Liverpool to join Saudi's Al-Hilal
-
Sinner storms to quick-fire opening win in Cincinnati
-
Thousands protest in Tel Aviv against Israeli govt move to expand Gaza war
-
Colombian presidential hopeful in critical condition again: doctors
-
PSG complete signing of French goalkeeper Chevalier
-
Four astronauts home from space station after splashdown
-
US star Chen will not defend Olympic figure skating gold in Italy
-
Chad court jails ex-PM, opposition leader for 20 years
-
Momentum sagging at UN plastic pollution treaty talks
-
Designer says regrets Adidas 'appropriated' Mexican footwear
-
UK arrests 365 backing banned pro-Palestine group
-
Pawol becomes first woman to umpire in MLB
-
Norris 'all good' after NFL game-stopping pre-season injury
-
Russia cautious on Armenia-Azerbaijan deal, Iran reject border corridor
-
West Ham sign Leicester goalkeeper Hermansen
-
Overcrowded French prison swelters in 'unbearable' heat
-
UK arrests 200 backing banned pro-Palestine group
-
Four astronauts leave space station for trip back to Earth
-
UN plastic pollution treaty talks floundering
-
Death toll from northwest China floods rises to 13
-
Greeks count cost of wildfire 'tragedy' near Athens
-
Historic Spanish mosque-cathedral reopens after blaze
-
Massive French wildfire contained but 'not under control'
-
Sesko completes Manchester United's new-look forward line-up
-
Manchester United sign forward Benjamin Sesko: club
-
Kyiv won't give up land, says Zelensky as US-Russia summit confirmed
-
Kyiv won't give up land, says Zelensky as US-Russia confirm summit
-
North Korea removing border loudspeakers: Seoul military
-
Gunman kills police officer near Atlanta CDC headquarters
-
Mexico discounts risk of 'invasion' after Trump order to target cartels
-
Nawaz sparks Pakistan to five-wicket ODI win over West Indies
-
Lions' Norris hospitalized after scary injury, NFL pre-season game suspended
-
Restored Nagasaki bell rings in 80 years since A-bomb
-
Putin-Trump summit: what we know so far
-
Australia settle on Marsh and Head as T20 openers
-
New York declares total war on prolific rat population
-
Patriots unveil statue honoring iconic quarterback Tom Brady
RBGPF | 1.7% | 73.08 | $ | |
JRI | 0.19% | 13.435 | $ | |
BCC | -1.34% | 82.09 | $ | |
CMSD | 0.25% | 23.58 | $ | |
SCS | -0.76% | 15.88 | $ | |
VOD | 0.88% | 11.36 | $ | |
RIO | 1.76% | 61.86 | $ | |
SCU | 0% | 12.72 | $ | |
RELX | -2.2% | 48 | $ | |
RYCEF | -0.14% | 14.42 | $ | |
NGG | -1.51% | 71.01 | $ | |
CMSC | 0.39% | 23.05 | $ | |
BCE | 2.34% | 24.35 | $ | |
GSK | 0.58% | 37.8 | $ | |
AZN | -0.69% | 73.55 | $ | |
BP | -0.15% | 34.14 | $ | |
BTI | 0.96% | 57.24 | $ |

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market
ESTERO, FL / ACCESS Newswire / July 22, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced it plans to launch its newsublingual pre-workout supplement, BUZZ BOMB™, at FitCon and FitExpo, two of the largest fitness conventions held annually in Salt Lake City, Utah (August 1-2) and Anaheim, CA, (August 2-3), respectively.
Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Buzz BOMB™, offered in four flavors, provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB™ is sprinkled under the tongue for immediate effect.
FitCon: Mountain America ExpoCenter, Salt Lake City, UT on August 1-2, 2025, Located in Sponsor Alley
FitCon is an event that brings together fitness enthusiasts, professionals, brands, and influencers in the health and wellness industry with approximately 20,000 attendees and hundreds of exhibitors. BUZZ BOMB™ is one of seven "Gold Sponsors" at FitCon, which provides benefits including samples provided to every attendee, a large booth located along "Sponsor Alley" where all attendees pass through, as well as FitCon website marketing, advertising and communications to attendees, and a liberal exhibiting of Buzz Bomb's distinctive trademark throughout the exhibition.
To learn more about FitCon, please visit https://fitcon.com/
The FitExpo: Anaheim Convention Center, Anaheim, CA, August 2-3, 2025, Booth #401
FitExpo brings together a diverse range of fitness brands, competitions, and demonstrations to inspire and guide individuals on their fitness journey and is one of the largest fitness conventions in the world with over 33,000 people expected to attend. As a convention sponsor, BUZZ BOMB™ will be provided numerous benefits and support, including:
Booth # 401 is the first one nearest the entry doors to the convention
FitExpo will publish a pre-convention media blast about BUZZ BOMB™ to over 1.8 million social media accounts including all attendees
BUZZ BOMB™ will be mentioned on all signage throughout the convention, including in the lobby where patrons enter, as well as on the convention's website, newsletter, and social media postings
BUZZ BOMB™ products will be in the gift bag given to every entrant (a sample pack of 4 different flavors)
BUZZ BOMB is planned to be personally introduced to each influencer at the show
Learn more about FitExpo at https://thefitexpo.com/cities/anaheim/
Company representatives (mostly professional trainers) will be running "Feel the Buzz" contests at both conventions with 250 BUZZ BOMB™ t-shirts offered as prizes to contestants. The Company also plans to sell product at the conventions and generate "BUZZ".
"The launch of BUZZ BOMB™ at two of the major fitness conventions represent the ideal venues to introduce our disruptive pre-workout formula designed to boost endurance, energy metabolism, and overall performance, ensuring that athletes and fitness enthusiasts can perform at their best, both in and out of the gym," said Michael Howe, Chief Executive Officer of Aspire. "We are also very excited about the positive initial consumer feedback we received recently from our sampling of BUZZ BOMB™ to not only fitness trainers and gym owners, but to active and fitness-minded consumers, expanding the addressable market opportunity within the multi-billion-dollar health and wellness categories."
BUZZ BOMB™ Pre-workout Benefits:
• Speed - works nearly immediate vs. 20-30 minutes
• Convenience - easy to use single-use packets vs. mixing and measuring for beverages
• Energy management - use as needed to precisely manage caffeine intake
• Single Safe Active Ingredient - well-known benefits and use of caffeine
• Low manufacturing & packaging costs - competitive pricing with high margin potential
About the Aspire Targeted Oral Delivery Platform
Aspire's technology delivers fast-acting supplement formulations which have been developed by using our patent-pending methodology, and "trade secret" process. The technology's new mechanism of action allows for rapid sublingual absorption. The benefits of "rapid absorption" are to provide rapid impact in more precise quantities.
About Aspire Biopharma, Inc.
Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
L.Miller--AMWN